Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology - 1 Nov 2010

Yang J-C, Lee P-I, Hsueh P-R

Abstract excerpt

The minimum inhibitory concentrations (MICs) of 330 nonduplicate Helicobacter pylori isolates to nemonoxacin, tigecycline, and eight other antimicrobial agents were determined by using the agar dilution method. Sequencing the quinolone resistance-determining regions (QRDRs) in the gyrA gene of th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amoxicillin
Share to Aza Compounds
Share to Levofloxacin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Minocycline

Share to Moxifloxacin

Share to Naphthyridines

Share to Tetracyclines

Share to Tigecycline

Source

Identifiers

PMID: 20658256
DOI: 10.1007/s10096-010-1009-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20658256-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.PMID 20658256Read ↗

Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.Semantic proximity Read ↗

In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in TaiwanSemantic proximity Read ↗

Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in ChinaSemantic proximity Read ↗

Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in NingxiaSemantic proximity Read ↗

Geographically distinct North-East Indian Helicobacter pylori strains are highly sensitive to clarithromycin but are levofloxacin resistant.Semantic proximity Read ↗

In vitro anti-Helicobacter pylori activity and phenotypic screening of novel quinolone compounds.Semantic proximity Read ↗

Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole-genome sequencing-based study in Southern China.Semantic proximity Read ↗

Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistanceSemantic proximity Read ↗

In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.Semantic proximity Read ↗

Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014).Semantic proximity Read ↗

Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.Semantic proximity Read ↗

Update on quinolone-containing rescue therapies for Helicobacter pylori infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.